4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-007083
CHAIRMAN & CEO sold 18,324 shares at an average $21.34 ($391,056)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Sanj K CHAIRMAN & CEO | 2024-03-04 | Sale 10b5-1 | −9,406 | $21.31 | $200,442 | 73,930 | I |
| Patel Sanj K CHAIRMAN & CEO | 2024-03-04 | Sale 10b5-1 | −3,336 | $22.00 | $73,392 | 70,594 | I |
| Patel Sanj K CHAIRMAN & CEO | 2024-03-06 | Sale 10b5-1 | −5,582 | $21.00 | $117,222 | 65,012 | I |
| Open-market sales · 18,324 sh · avg $21.34 · $391,056 | |||||||
Loading xslF345X05/form4-03062024_100330.xml…